Clinical Trial Update: Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban. [NA]

View source ↗

Summary

ClinicalTrials.gov entry describing a trial comparing blood loss after total hip arthroplasty using three thromboprophylaxis regimens: dabigatran, enoxaparin, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Osteoarthritis

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Enoxaparin (enoxaparin sodium)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Centre of Postgraduate Medical Education | Conditions: Hip Osteoarthritis, Blood Loss | NA | Status: UNKNOWN